LIraglutide and Beta-cell RepAir (LIBRA) Study

Clinical trial NCT01270789 · COMPLETED

Trial details

NCT number: NCT01270789
Sponsor: Mount Sinai Hospital, Canada
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2011-01-01
Primary completion: 2013-12-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.